Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- P/B of 10.55 — trading above book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -148.8%
- Dividend yield of 3.8%
The Chemours Company (CC) is a Basic Materials company operating in Chemicals & Allied Products, listed on the NYSE , with a market capitalisation of $2.6 billion . Key value metrics: P/B ratio 10.55, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
The Chemours Company — Fundamental Analysis Summary
On financial health, CC shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -148.8% (sector average: -1.2%), and high leverage with a debt-to-equity ratio of 16.56.
StockPik's composite Value Score for CC is 29/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CC shows revenue growing at 0% year-over-year, with earnings declining at 549%.
CC pays a solid dividend yield of 3.8%.